Covaxin Pharmaceuticals has reached a commercial cooperation agreement with Changzhou Pharmaceutical Factory for two cardiovascular drugs in Europe.

News from CStone Pharmaceuticals: Recently, the company held a strategic cooperation and exclusive licensing signing ceremony with Changzhou Pharmaceutical Factory Co., Ltd., a subsidiary of Shanghai Pharmaceuticals Group, for the overseas markets of two products, Tegrital and Rosuvastatin Calcium tablets, in multiple European countries. The two parties will work together to expand the European market. Tegrital and Rosuvastatin Calcium tablets are both cardiovascular disease treatment drugs with significant clinical value and broad market prospects. Tegrital, in combination with acetyl salicylic acid, is used to prevent atherosclerotic thrombotic events in patients with acute coronary syndrome, or in patients with a history of myocardial infarction and a high risk of atherosclerotic thrombotic events.